Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Two new mutants, 'trembler' and 'reeler', with neurological actions in the house mouse (Mus musculus L.).

FALCONER DS.

J Genet. 1951 Jan;50(2):192-201. No abstract available.

PMID:
24539699
2.

Microbial Status and Genetic Evaluation of Mice and Rats: Proceedings of the 1999 US/Japan Conference.

National Research Council (US) International Committee of the Institute for Laboratory Animal Research.

Washington (DC): National Academies Press (US); 2000.

3.

X-ray-induced mutations in mice.

RUSSELL WL.

Cold Spring Harb Symp Quant Biol. 1951;16:327-36. No abstract available.

PMID:
14942747
4.

Risks of Infection among Laboratory Rats and Mice at Major Biomedical Research Institutions.

Jacoby RO, Lindsey JR.

ILAR J. 1998;39(4):266-271. No abstract available.

PMID:
11528087
5.

Paw withdrawal threshold in the von Frey hair test is influenced by the surface on which the rat stands.

Pitcher GM, Ritchie J, Henry JL.

J Neurosci Methods. 1999 Mar 1;87(2):185-93.

PMID:
11230815
6.
7.

Understanding corticotropin releasing factor neurobiology: contributions from mutant mice.

Contarino A, Heinrichs SC, Gold LH.

Neuropeptides. 1999 Feb;33(1):1-12. Review.

PMID:
10657465
8.

The disabled 1 gene is disrupted by a replacement with L1 fragment in yotari mice.

Kojima T, Nakajima K, Mikoshiba K.

Brain Res Mol Brain Res. 2000 Jan 10;75(1):121-7.

PMID:
10648895
9.

Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation.

Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, Herz J.

Neuron. 1999 Oct;24(2):481-9.

10.

Reelin is a ligand for lipoprotein receptors.

D'Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran T.

Neuron. 1999 Oct;24(2):471-9.

11.

Warning: the use of heterogeneous mice may seriously damage your research.

Festing MF.

Neurobiol Aging. 1999 Mar-Apr;20(2):237-44; discussion 245-6. Review.

PMID:
10537033
12.

Pharmacogenomics: translating functional genomics into rational therapeutics.

Evans WE, Relling MV.

Science. 1999 Oct 15;286(5439):487-91. Review.

PMID:
10521338
13.

Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice.

Chinen CC, Frussa-Filho R.

Neuropsychopharmacology. 1999 Nov;21(5):670-8.

14.

Knock-out mouse models used to study neurobiological systems.

Picciotto MR.

Crit Rev Neurobiol. 1999;13(2):103-49. Review.

PMID:
10512487
15.

Humoral immunity and protection of mice challenged with homotypic or heterotypic parvovirus.

Hansen GM, Paturzo FX, Smith AL.

Lab Anim Sci. 1999 Aug;49(4):380-4.

PMID:
10480642
16.

Genetic variation in susceptibility to endocrine disruption by estrogen in mice.

Spearow JL, Doemeny P, Sera R, Leffler R, Barkley M.

Science. 1999 Aug 20;285(5431):1259-61.

17.
19.

Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1.

Contarino A, Dellu F, Koob GF, Smith GW, Lee KF, Vale W, Gold LH.

Brain Res. 1999 Jul 17;835(1):1-9.

PMID:
10448190
20.

Cutting edge: homologous recombination of the MHC class I K region defines new MHC-linked diabetogenic susceptibility gene(s) in nonobese diabetic mice.

Hattori M, Yamato E, Itoh N, Senpuku H, Fujisawa T, Yoshino M, Fukuda M, Matsumoto E, Toyonaga T, Nakagawa I, Petruzzelli M, McMurray A, Weiner H, Sagai T, Moriwaki K, Shiroishi T, Maron R, Lund T.

J Immunol. 1999 Aug 15;163(4):1721-4.

Supplemental Content

Support Center